Inge van der Sluis
0000-0002-5822-7668
4 papers found
Refreshing results…
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups
High prevalence of parent‐reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy
Pharmacokinetics and population pharmacokinetics in pediatric oncology
Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group
Missing publications? Search for publications with a matching author name.